Trends in the incidence of cervical cancer and severe precancerous lesions in Denmark, 1997–2012

[1]  A. Pellicer,et al.  Overview of current trends in hysterectomy , 2009 .

[2]  C. Dehlendorff,et al.  Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program , 2014, Cancer Causes & Control.

[3]  S. Kjaer,et al.  Early impact of human papillomavirus vaccination on cervical neoplasia--nationwide follow-up of young Danish women. , 2014, Journal of the National Cancer Institute.

[4]  E. Lynge,et al.  Introduction of human papillomavirus vaccination in Nordic countries. , 2012, Vaccine.

[5]  P. Boyle,et al.  A birth cohort analysis of the incidence of adenocarcinoma of the uterine cervix in the USA , 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[6]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.

[7]  S. Franceschi,et al.  Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update , 2007, International journal of cancer.

[8]  T. Iftner,et al.  Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention? , 2013, Cancer Causes & Control.

[9]  Maria Hortlund,et al.  Targeting Human Papillomavirus to Reduce the Burden of Cervical, Vulvar and Vaginal Cancer and Pre-Invasive Neoplasia: Establishing the Baseline for Surveillance , 2014, PloS one.

[10]  M. Stanley.  Pathology and epidemiology of HPV infection in females. , 2010, Gynecologic oncology.

[11]  Marc Arbyn,et al.  Liquid Compared With Conventional Cervical Cytology: A Systematic Review and Meta-analysis , 2008, Obstetrics and gynecology.

[12]  黄亚明.  MedScape , 2009 .

[13]  F. Bray,et al.  50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence , 2014, British Journal of Cancer.

[14]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[15]  E. Lynge,et al.  Hysterectomy and its impact on the calculated incidence of cervical cancer and screening coverage in Denmark , 2015, Acta oncologica.

[16]  B. Bjerregaard,et al.  Non-participation in screening: the case of cervical cancer in Denmark. , 2012, Preventive medicine.

[17]  Xavier Castellsagué,et al.  Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. , 2006, Journal of the National Cancer Institute.

[18]  D. Jenkins,et al.  Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination , 2013, BMC Cancer.

[19]  E. Lynge,et al.  Frequency of cervical intraepithelial neoplasia treatment in a well‐screened population , 2012, International journal of cancer.

[20]  K Sigurdsson,et al.  The Icelandic and Nordic cervical screening programs, Trends in incidence and mortality rates through 1995 , 1999, Acta obstetricia et gynecologica Scandinavica.

[21]  F. Bray,et al.  Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening , 2005, Cancer Epidemiology Biomarkers & Prevention.

[22]  Rafael Lozano,et al.  AGE STANDARDIZATION OF RATES: A NEW WHO STANDARD , 2000 .

[23]  A. Settnes,et al.  Use of vaginal hysterectomy in Denmark: rates, indications and patient characteristics , 2011, Acta obstetricia et gynecologica Scandinavica.

[24]  M. Plummer,et al.  Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. , 2013, European journal of cancer.

[25]  Mark Schiffman,et al.  Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. , 2011, The Lancet. Oncology.

[26]  B. Monk,et al.  Adenocarcinoma of the Uterine Cervix: Why Is it Different? , 2014, Current Oncology Reports.

[27]  A. Giuliano,et al.  Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity , 2009, Cancer Causes & Control.

[28]  E. Lynge,et al.  Impact of technology on cytology outcome in cervical cancer screening of young and older women , 2014, International journal of cancer.

[29]  F. Bray,et al.  Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries , 2005, Cancer Epidemiology Biomarkers & Prevention.

[30]  H. Kitchener,et al.  Increasing rates of cervical cancer in young women in England: an analysis of national data 1982–2006 , 2011, British Journal of Cancer.

[31]  M. Sherman,et al.  Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000 , 2004, Cancer.

[32]  K. Smith-McCune,et al.  Cervical Cancer Screening , 2016, Obstetrics and gynecology.

[33]  B. Rosen,et al.  Decreasing incidence of cervical adenocarcinoma in Ontario: Is this related to improved endocervical Pap test sampling? , 2007, International journal of cancer.

[34]  J. Dillner,et al.  Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection. , 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[35]  Eileen M. Burd,et al.  Human Papillomavirus and Cervical Cancer , 1988, The Lancet.

[36]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[37]  M. Schiffman,et al.  Updating the natural history of human papillomavirus and anogenital cancers. , 2012, Vaccine.

[38]  S. Ciatto,et al.  Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985-2000. , 2004, Cancer Detection and Prevention.

[39]  E. Lynge,et al.  Outcomes in cervical screening using various cytology technologies: What’s age got to do with it? , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[40]  A. Miller,et al.  Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006 , 2012, BMC Public Health.

[41]  S. Kulasingam,et al.  Cervical cancer trends in the United States: a 35-year population-based analysis. , 2012, Journal of women's health.

[42]  Marianne Lundkjær Gjerstorff,et al.  The Danish Cancer Registry , 2011, Scandinavian journal of public health.

[43]  M. van Ballegooijen,et al.  Trends in cervical cancer in the Netherlands until 2007: Has the bottom been reached? , 2011, International journal of cancer.

[44]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[45]  M. Seoud,et al.  Cervical adenocarcinoma: moving towards better prevention. , 2011, Vaccine.

[46]  K. Frederiksen,et al.  Cervical cancer incidence in Denmark over six decades (1943–2002) , 2006, Acta obstetricia et gynecologica Scandinavica.